12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Tuesday's after-market session. Notable gainers included Axcella Health (AXLA), Carmell Therapeutics (CTCX), ContraFect (CFRX), Infinity Pharmaceuticals (INFI), Beyond Air (XAIR), and Healthcare Triangle (HCTI). On the other hand, FibroGen (FGEN), TransCode Therapeutics (RNAZ), Precipio (PRPO), AEON Biopharma (AEON), Vaccinex (VCNX), and NanoVibronix (NAOV) saw their stocks decline.
August 29, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
FibroGen's shares declined by 18.0% to $1.05 during Tuesday's after-market session.
The significant decline in FibroGen's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics' stock decreased by 12.8% to $1.5.
The decrease in TransCode Therapeutics' stock price is likely to negatively affect its short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Axcella Health's stock rose 14.4% to $0.52 during Tuesday's after-market session.
The significant increase in Axcella Health's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Carmell Therapeutics' stock moved upwards by 8.69% to $4.0.
The upward movement in Carmell Therapeutics' stock price is likely to positively affect its short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100